Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$63.83 - $80.0 $226,596 - $284,000
-3,550 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$76.85 - $89.45 $272,817 - $317,547
3,550 New
3,550 $275,000
Q1 2021

May 14, 2021

SELL
$76.38 - $86.03 $194,998 - $219,634
-2,553 Closed
0 $0
Q4 2020

Feb 11, 2021

SELL
$75.39 - $82.36 $68,454 - $74,782
-908 Reduced 26.24%
2,553 $205,000
Q3 2020

Nov 10, 2020

SELL
$78.33 - $90.73 $31,410 - $36,382
-401 Reduced 10.38%
3,461 $278,000
Q2 2020

Aug 10, 2020

SELL
$78.66 - $94.14 $46,802 - $56,013
-595 Reduced 13.35%
3,862 $332,000
Q1 2020

May 12, 2020

SELL
$71.57 - $93.3 $20,970 - $27,336
-293 Reduced 6.17%
4,457 $407,000
Q4 2019

Jan 24, 2020

SELL
$76.7 - $88.45 $418,935 - $483,113
-5,462 Reduced 53.49%
4,750 $397,000
Q3 2019

Nov 05, 2019

SELL
$81.4 - $89.78 $148,310 - $163,579
-1,822 Reduced 15.14%
10,212 $893,000
Q2 2019

Jul 18, 2019

SELL
$73.44 - $82.41 $75,936 - $85,211
-1,034 Reduced 7.91%
12,034 $986,000
Q1 2019

Apr 18, 2019

BUY
$64.48 - $81.31 $249,279 - $314,344
3,866 Added 42.01%
13,068 $1.06 Million
Q4 2018

Jan 25, 2019

BUY
$61.45 - $77.8 $49,221 - $62,317
801 Added 9.53%
9,202 $606,000
Q3 2018

Oct 17, 2018

BUY
$70.71 - $77.75 $44,830 - $49,293
634 Added 8.16%
8,401 $628,000
Q2 2018

Jul 27, 2018

BUY
$63.43 - $75.41 $144,747 - $172,085
2,282 Added 41.6%
7,767 $573,000
Q1 2018

Apr 06, 2018

SELL
$62.56 - $72.26 $752,909 - $869,649
-12,035 Reduced 68.69%
5,485 $357,000
Q4 2017

Jan 25, 2018

BUY
$61.45 - $66.05 $371,280 - $399,074
6,042 Added 52.64%
17,520 $1.13 Million
Q3 2017

Oct 03, 2017

BUY
$59.5 - $64.61 $682,941 - $741,593
11,478
11,478 $720,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.7B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Eqis Capital Management, Inc. Portfolio

Follow Eqis Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.